IKT-001 — Interim data
1H 2027
1H 2027 Interim safety readout for Part A of Phase 3 IMPROVE-PAH Study (n=50)Source filing
IKT biotech catalysts & pipeline
INHIBIKASE THERAPEUTICS INC · Data as of 2026-10-25
Upcoming catalysts
IKT-001 — Clinical data readout
Mid 2028
Mid 2028 Unblinded Data (PVR reduction) readout for Part A of Phase 3 IMPROVE-PAH Study (n=120)Source filing
IKT-001 — Topline data
Mid 2029
Mid 2029 Topline 6MWD readout from Part B of Phase 3 IMPROVE-PAH Study (n=300)Source filing